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Macrophage-secreted granulin supports pancreatic
cancer metastasis by inducing liver fibrosis
Sebastian R. Nielsen1, Valeria Quaranta1, Andrea Linford1, Perpetua Emeagi1, Carolyn Rainer1,
Almudena Santos1, Lucy Ireland1, Takao Sakai2, Keiko Sakai2, Yong-Sam Kim3,4, Dannielle Engle5,6,
Fiona Campbell1, Daniel Palmer1, Jeong Heon Ko3,4, David A. Tuveson5,6,7, Emilio Hirsch8, Ainhoa Mielgo1
and Michael C. Schmid1,9
Pancreatic ductal adenocarcinoma (PDAC) is a devastating metastatic disease for which better therapies are urgently needed.
Macrophages enhance metastasis in many cancer types; however, the role of macrophages in PDAC liver metastasis remains poorly
understood. Here we found that PDAC liver metastasis critically depends on the early recruitment of granulin-secreting
inflammatory monocytes to the liver. Mechanistically, we demonstrate that granulin secretion by metastasis-associated
macrophages (MAMs) activates resident hepatic stellate cells (hStCs) into myofibroblasts that secrete periostin, resulting in a
fibrotic microenvironment that sustains metastatic tumour growth. Disruption of MAM recruitment or genetic depletion of granulin
reduced hStC activation and liver metastasis. Interestingly, we found that circulating monocytes and hepatic MAMs in PDAC
patients express high levels of granulin. These findings suggest that recruitment of granulin-expressing inflammatory monocytes
plays a key role in PDAC metastasis and may serve as a potential therapeutic target for PDAC liver metastasis.
Pancreatic cancer is among the most lethal cancers in part owing to
its aggressive metastatic nature1,2. Metastatic spreading is a multistage
process, which starts with the dissemination of cancer cells from the
primary tumour site and ends with clinically detectable metastatic
outgrowth at distant organs. Tumours can release large numbers
of cancer cells into the circulation, but only a small proportion of
these cells are able to successfully survive and colonize the hostile
environment at the distant metastatic site3,4. Thus, the successful
outgrowth of metastatic tumour cells in this new distant environment
is a severe rate-limiting step during metastasis. Emerging evidence
indicates that the colonization of a new organ by metastatic tumour
cells critically depends on the support of non-cancerous stromal
partners5–8. Multiple steps of the metastatic cascade are supported
by stromal partners, particularly macrophages and, in many cancers,
metastasis correlates with increased macrophages at the metastatic
site9–14. PDAC is characterized by its formation of ductal structures
and a rich stromal compartment containingmainly fibroblasts, stellate
cells and infiltrating immune cells. In response to the presence of
tumour cells, quiescent fibroblasts and stellate cells become activated
myofibroblasts that express alpha smooth muscle actin15 (αSMA). In
non-pathological conditions, myofibroblasts are critical for wound
healing16. In cancer, the role of myofibroblasts is controversial at
present. Previous studies have suggested that myofibroblasts support
tumour growth and restrict the delivery of chemotherapeutic drugs
to the tumour17–19. However, recent reports have shown that genetic
depletion of myofibroblasts results in tumour progression and
metastasis20,21.Most pancreatic cancer studies have focused on the role
of stromal partners at the primary site; however, the role of stromal
cells at the secondary metastatic site, which for PDAC is most often
the liver, remains poorly understood.
At the moment, the best treatment option for PDAC patients
is resection of the pancreatic tumour, but, unfortunately, by the
time PDAC patients are diagnosed, most (∼80%) present with
non-resectable metastatic cancer. Moreover, more than 60% of the
patients whose tumours are resected, relapse with distant hepatic
recurrence within the first 24 months after surgery22,23. Thus, a better
understanding of themechanisms underlying themetastatic process in
pancreatic cancer is critical to improve treatment and patient outcome.
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Figure 1 Metastatic PDAC cells induce macrophage recruitment and
activation of myofibroblasts in the liver. (a) Identification of pan-cytokeratin
(CK)+ metastatic pancreatic cancer cells, haematopoietic cells (CD45+),
macrophages (CD68+) and myofibroblasts (αSMA+) as predominant cell
types in the hepatic metastatic microenvironment of pancreatic cancer
by immunohistochemical analysis of human biopsies. Representative
micrographs and quantification of the data are shown (n = 5 PDAC
patients, n=5 healthy subjects; five fields assessed per sample; mean ±
s.e.m.; two-tailed unpaired t-test). HL, healthy liver; LM, liver metastasis;
FOV, field of view. (b) Established metastatic nodules in the liver were
processed 12 days post intrasplenic implantation of 1 × 106 KPCs and
analysed by flow cytometry. Composition of intrametastatic leukocytes is
shown as a percentage of CD45+ cells using the following definitions:
B cells (CD45+CD3negB220+); T cells (CD45+B220negCD3+), NK cells
(CD45+B220negCD3negNK1.1+), neutrophils (CD11b+Ly6G+F4/80neg), MAMs
(CD11b+F4/80+) (n=4 healthy livers; n=8 liver metastasis; data combine
two independent experiments; mean ± s.e.m.; two-tailed unpaired t-test).
(c) Representative immunofluorescence staining of myofibroblasts (αSMA+)
clustering around metastatic KPCluc/zsGreen (zsGreen) cancer cells in the liver
at 5 and 12 days after implantation. Histogram: quantification of myeloid
(CD11b+) and myofibroblast (αSMA+) cell frequency in livers during the
course of metastasis formation. Nuclei were counterstained with DAPI
(n=6 mice per time point; four fields assessed per sample; data combine
two independent experiments; mean ± s.e.m.; two-tailed unpaired t-test).
(d) Representative Masson’s trichrome staining (MTS) of tumour-bearing
livers at 5 and 12 days after implantation. Histogram: quantification of area
occupied by fibrotic stroma (n=6 mice per time point; four fields assessed
per sample; data combine two independent experiments; mean ± s.e.m.;
two-tailed unpaired t-test). (e) Schematic of the generation of chimaeric mice
resulting in tdTomatoRed-positive BM-derived macrophages and non-labelled
resident Kupffer cells (KCs). (f) Chimaeric mice from e were intrasplenically
implanted with 1 × 106 Panc02 cells and livers were collected after day
12. Immunofluorescence analysis of BM-derived tdTomatoRed+ cells in
combination with F4/80 staining and αSMA staining in tumour-bearing livers.
Nuclei were counterstained with DAPI (data are from six mice per condition;
one experiment). Scale bars, 100 µm; NS, not significant.
RESULTS
Metastatic PDAC cells trigger macrophage recruitment and an
extensive stromal response in the liver
The most common route of PDAC metastasis is to the liver. To
understand whether and how stromal cells influence liver PDAC
metastasis, we first analysed liver biopsies from advanced metastatic
PDAC patients and healthy volunteers by immunohistochemical
and immunofluorescence techniques. We found that metastatic
tumour cells (cytokeratin+) are surrounded by an abnormal stromal
compartment rich in haematopoietic immune cells (CD45+),
macrophages (CD68+), myofibroblasts (αSMA+; PDGFRα+) and
connective tissue deposition (Fig. 1a and Supplementary Fig. 1a–c).
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Figure 2 Macrophages promote myofibroblast activation and metastatic
growth. (a–d) Liver metastasis was induced by intrasplenic implantation
of 1 × 106 KPC cells. Entire livers were collected and analysed 12 days
later. (a) Haematopoietic cells (CD45+), MAMs (CD45+CD11b+F4/80+),
and IMs (CD45+CD11b+Ly6C+F4/80negLy6Gneg) from tumour-bearing livers
of WT versus PI(3)Kγ−/− mice were evaluated by flow cytometry (n=6 mice
WT; n= 8 mice PI(3)Kγ−/−; data combine two independent experiments;
individual data points, horizontal lines represent mean ± s.e.m.; two-tailed
unpaired t-test). (b,c) Quantification of metastatic frequency (b) and average
metastatic lesion size (c) in WT and PI(3)Kγ−/− mice by haematoxylin and
eosin-stained liver sections (n=7 mice WT; n=9 mice PI(3)Kγ−/−; data
combine two independent experiments; mean ± s.e.m.; two-tailed unpaired
t-test). (d) Representative immunofluorescence staining and quantification of
MAM (F4/80+) and myofibroblast (αSMA+) cell frequency in livers in WT and
PI(3)Kγ−/−. Nuclei were counterstained with DAPI (n=6mice WT; n=8mice
PI(3)Kγ−/−; four fields assessed per sample; data combine two independent
experiments; mean ± s.e.m.; two-tailed unpaired t-test). (e–h) Liver
metastasis was induced by intrasplenic implantation of 1 × 106 KPC cells.
Macrophages were depleted by clodronate liposome treatment after initial
colonization of the liver had occurred. (e) Schematic illustration of the
experiment. (f) Representative immunofluorescent staining and quantification
of MAM (F4/80+) and myofibroblast (αSMA+) cell frequency in tumour-
bearing livers treated with liposomes containing PBS (PL) or clodronate (CL).
Nuclei were counterstained with DAPI (n=4 mice per condition; five fields
assessed per sample; one experiment; mean ± s.e.m.; two-tailed unpaired
t-test). (g,h) Evaluation of metastatic frequency (g) and area covered by
metastatic cells (h) in tumour-bearing livers of mice treated with PL or CL
(n=4 mice per condition; all metastatic nodules assessed from one section
per sample; one experiment; individual data and mean ± s.e.m.; two-tailed
unpaired t-test). Scale bars, 100 µm; NS, not significant.
To further evaluate the type of immune cells accumulating at
the metastatic site, we intrasplenically injected KPC-derived cells
(FC1199), isolated from the genetically engineered mouse model
of PDAC (KrasG12D; Trp53R172H ; Pdx1–Cre mice)24. In this model,
tumour cells migrate to the liver through the portal circulation
(a common way of metastasis occurring in humans)25,26, and generate
metastases restricted to the liver (Supplementary Fig. 1d). We
analysed established metastatic tumours at day 12, by flow cytometry,
and found that the percentages of CD45+ immune cells, B220+ B
cells, CD3+ T cells, Nk1.1+ NK cells, CD11b+Ly6G+ neutrophils,
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Figure 3 Granulin secreted by macrophages activates hepatic stellate cells.
(a) Quantification of αSMA (Acta2), and collagen 1a (Col1a) mRNA levels
in primary hStCs stimulated with isogenic macrophage-conditioned media
(MCM) generated from WT or granulin-deficient (Grn−/−) macrophages, and
MCM generated from Grn−/− macrophages in the presence of recombinant
granulin (rGranulin) as determined by qPCR (n=3 independent experiments;
mean ± s.e.m.; two-tailed unpaired t-test). (b) Quantification of hStC
invasion towards MCM generated from WT or Grn−/− macrophages and
MCM generated from Grn−/− macrophages in the presence of rGranulin
(n=3 independent experiments; mean ± s.e.m.; two-tailed unpaired t-test).
(c,d) The same as in a,b, but MCM was generated using in vivo-derived
MAMs. Therefore, liver metastasis was induced by intrasplenic implantation
of 1 × 106 KPC cells into isogenic WT + WT BM and WT + Grn−/− BM
chimaeric mice (n=3 independent experiments; mean ± s.e.m.; two-tailed
unpaired t-test). (e) Representative immunofluorescence images of d showing
Vybrant Dil (Em565)-labelled murine hStCs showing invasion towards MCM
generated from WT and Grn−/− MAMs and MCM generated from Grn−/−
MAMs in the presence of recombinant granulin (rGranulin) (data are from
three independent experiments). (f,g) Quantification of Grn mRNA levels
by qPCR (f) and granulin secretion by ELISA (g) in primary unstimulated
(M0) macrophages and macrophages stimulated with isogenic conditioned
media (CM) generated from murine KPC and Panc02 tumour cells (n=3
independent experiments; mean ± s.e.m.; two-tailed unpaired t-test).
Scale bar, 100 µm.
and F4/80+ macrophages were increased in tumour-bearing livers
compared with tumour free livers (Supplementary Fig. 2a–c).
However, among the CD45+ immune cells, metastasis-associated
macrophages (MAMs; CD11b+F4/80+Ly6GnegCCR2+) were the
most predominant cell population (Fig. 1b, Supplementary Figs 2d
and 3a,b). Interestingly, metastatic tumour cells initially induced
a rapid accumulation of CD11b+F4/80negLy6C+LY6GnegCCR2+
inflammatory monocytes (IMs) followed by an accumulation of
MAMs (Supplementary Fig. 3a). In contrast, accumulation of
αSMA+ myofibroblasts and stromal expansion were detected only
in established experimental and spontaneous metastatic lesions
(Fig. 1c,d and Supplementary Fig. 3b–g).
Macrophages in the liver can be broadly categorized into two
classes: embryonically derived tissue-resident macrophages known
as Kupffer cells (KCs), and infiltrating macrophages derived from
IMs that originate from the bone marrow27–30 (BM). To investigate
whether the increased number of MAMs we observe is due to an
expansion of resident KCs or to the recruitment of BM-derived cells,
we generated BM chimaeras by engrafting tdTomato red (tdTomato)
BM into irradiated wild-type mice (WT + tdTomato+ BM) or
WT BM into irradiated WT mice (WT + WT BM). As KCs in
the liver are radio-resistant31, they remain of host origin and are
therefore F4/80+ tdTomatoneg, whereas BM-derived macrophages are
of donor origin and F4/80+ tdTomato+ (Fig. 1e). After confirming
successful BM reconstitution (Supplementary Fig. 3h), chimaeric
mice were intrasplenically implanted with the murine PDAC cell
line Panc0232. We found that MAMs were exclusively tdTomato+,
and, thus, derived from BM (Fig. 1f and Supplementary Fig. 3i).
Conversely, in adjacent ‘normal liver tissue’, F4/80+ macrophages
remained tdTomatoneg, consistent with resident F4/80+ KCs (Fig. 1f).
In addition, αSMA+ metastasis-associated myofibroblasts remained
tdTomatoneg, suggesting that these cells are not of BM origin, but
are locally activated mesenchymal cells, such as resident hepatic
stellate cells (hStCs) or fibroblasts (Fig. 1f and Supplementary Fig. 3j).
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Figure 4 Granulin is highly expressed in hepatic metastatic lesions
and metastasis-associated macrophages are the main source of granulin
secretion. (a,b) Quantification of Grn mRNA levels (a) and granulin protein
levels (b) in intrametastatic pancreatic cancer cells, immune-cell-depleted
stromal cells (zsGreennegCD45neg), and MAMs (CD45+F4/80+) isolated by
fluorescence-activated cell sorting from established tumour-bearing livers 12
days after intrasplenic implantation of 1 × 106 KPCluc/zsGreen cancer cells
(a, data are from three pooled mice; one experiment; b, n=3 independent
experiments; mean ± s.e.m.; two-tailed unpaired t-test). (c) Quantification
of Grn and Tgfb mRNA levels in tissue resident macrophages (KCs) and
MAMs sorted from established metastatic lesions from chimaeric WT mice
harbouring tdTomatoRed+ BM as described in Fig. 1g (data are from
three pooled mice; one experiment). (d) Spontaneous metastatic hepatic
tumours derived from KPC mice were isolated and analysed. Representative
images of immunohistochemistry staining for MAMs (CD68+) and granulin
expression on serial tissue sections from metastatic lesions and healthy
liver and quantification of the data (n = 5 control mice, n = 5 KPC
mice, five fields assessed per sample; mean ± s.e.m.; two-tailed unpaired
t-test). HL, healthy liver; LM, liver metastasis. (e) Representative images of
immunohistochemistry staining for MAMs (CD68+) and granulin expression
on serial tissue sections from human metastatic PDAC lesions and healthy
liver and quantification of the data (n= 5 healthy subjects, n= 5 PDAC
samples; five fields assessed per sample; mean ± s.e.m.; two-tailed unpaired
t-test). Scale bars, 100 µm; asterisks indicate matched tissue areas.
Together, our findings demonstrate that: in PDAC liver metastasis,
MAMs originate from IMs; MAMs represent the predominant
immune cell population in metastatic liver lesions; and MAM
accumulation in the liver precedes myofibroblast activation.
Macrophages promote myofibroblast activation and metastatic
growth
To determine the functional role of MAMs in pancreatic cancer
metastasis, we next intrasplenically implanted KPC cells into isogenic
PI(3)Kγ−/− mice (p110γ−/−)33 and control WT mice. PI(3)Kγ is
mainly expressed in the haematopoietic compartment, and PI(3)Kγ
knockout mice have a defect in monocyte recruitment in response
to inflammatory and tumour-derived signals34,35. As we previously
found that MAMs are IM-derived macrophages that are actively
recruited from the BM to the metastatic liver (Fig. 1f), we reasoned
that depletion of PI(3)Kγ will ablate IM trafficking to the metastatic
site and consequently abolishMAM accumulation in the liver. Indeed,
macrophage and IM numbers were significantly reduced in metastatic
livers of PI(3)Kγ−/− mice compared with WT mice as measured
by flow cytometry analysis (Fig. 2a). Importantly, PI(3)Kγ depletion
markedly reduced metastatic frequency, average metastatic lesion
size, and αSMA+ myofibroblast numbers, in both KPC (Fig. 2b–d
and Supplementary Fig. 4a) and Panc02 (Supplementary Fig. 4b–e)
liver-metastasis-bearing mice. Together, these results suggest that
inhibition of BM-derived macrophage recruitment to the liver
prevents pancreatic cancer metastasis to the liver and is accompanied
by a decrease in myofibroblast activation.
As most (∼80%) PDAC patients present with liver metastases
at the time of diagnosis, or relapse with hepatic recurrence after
surgical removal of primary pancreatic tumours1, we next focused our
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Figure 5 Granulin depletion prevents myofibroblast activation and PDAC
metastasis. (a–l) Liver metastasis was induced by intrasplenic implantation
of 5 × 105 KPC cells into WT and granulin-deficient (Grn−/−;) mice
(a–e) and chimaeric WT + WT BM and WT + Grn−/− BM mice (f–l).
Entire livers were collected and analysed 12 days later. (a) Representative
images of haematoxylin and eosin staining of liver sections (data are
from 6 WT and 7 Grn−/− mice; one experiment). (b) Metastatic frequency
(n = 6 WT mice, n = 7 Grn−/− mice; all metastatic nodules assessed
from one section per sample; one experiment; individual data points,
horizontal lines represent mean ± s.e.m.; two-tailed unpaired t-test).
(c) Metastatic area (n= 6 WT mice, n= 7 Grn−/− mice; all metastatic
nodules assessed from one section per sample; one experiment; mean ±
s.e.m.; two-tailed unpaired t-test). (d) Representative immunofluorescent
staining and quantification of MAM (F4/80+) and myofibroblast (αSMA+)
cell frequency in tumour-bearing livers. Nuclei were counterstained with
DAPI (n=6 WT mice, n=7 Grn−/− mice; four fields assessed per sample;
one experiment; mean ± s.e.m.; two-tailed unpaired t-test). (e) qPCR
analysis of multiple hStC activation markers in intrametastatic myofibroblasts
isolated from established metastatic lesions (data are from three pooled
mice per condition; one experiment). (f) Metastatic frequency (n=5 WT
+ WT BM mice, n=6 WT + Grn−/− BM mice; all metastatic nodules
assessed from one section per sample; one experiment; individual data
points, horizontal lines represent mean ± s.e.m.; two-tailed unpaired
t-test). (g) Metastatic area (n = 5 WT + WT BM mice, n = 6 WT +
Grn−/− BM mice; all metastatic nodules assessed from one section per
sample; one experiment; mean ± s.e.m.; two-tailed unpaired t-test). (h)
Representative immunofluorescence staining and quantification of MAM
(F4/80+) and myofibroblast (αSMA+) cell frequency in tumour-bearing livers.
Nuclei were counterstained with DAPI (n=5 WT + WT BM mice, n=6
WT + Grn−/− BM mice; four fields assessed per sample; one experiment;
mean ± s.e.m.; two-tailed unpaired t-test). (i) qPCR analysis of multiple
hStC activation markers in intrametastatic myofibroblasts isolated from
established metastatic lesions (data are from five pooled mice per condition;
one experiment). (j) qPCR analysis of multiple M2- and M1-macrophage-
associated genes in MAMs isolated from metastatic tumours developed in
WT + WT BM and WT + Grn−/− BM mice (data are from six pooled mice
per condition; one experiment). (k,l) Representative immunohistochemical
staining and quantification of Ki67+ tumour cell frequency (k) and cleaved
caspase 3+ cell numbers (l) in metastatic livers (n= 5 WT + WT BM
mice, n=6 WT + Grn−/− BM mice; five fields assessed per sample; one
experiment; mean ± s.e.m.; two-tailed unpaired t-test). Scale bars, 100m;
NS, not significant.
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Figure 6 Myofibroblast-secreted periostin enhances pancreatic cancer cell
growth. (a) Top gene ontology (GO) functions of secreted proteins enriched
in human myofibroblasts (Mf) following in vitro education with macrophage-
conditioned media (CM). (b) Fold change rank of identified proteins
associated with ECM organization. Data were obtained from one experiment
assessing two biologically independent samples (green, periostin). (c) Colony-
formation assay of primary murine KPC cells, murine Panc02, and human
Panc1 cells in the presence or absence of Mf CM and periostin-neutralizing
antibody (anti-periostin). Representative images reflecting colonies and
single cells are shown for KPC cells (n = 3 independent experiments;
mean ± s.e.m.; two-tailed unpaired t-test). (d) Immunohistochemical (IHC)
staining of periostin in human liver biopsies (n = 5 healthy subjects,
n= 5 PDAC; five fields assessed per sample; mean ± s.e.m.; two-tailed
unpaired t-test) and in spontaneous metastatic liver tumours collected
from KPC mice (n=5 mice per condition; five fields assessed per sample,
mean ± s.e.m.; two-tailed unpaired t-test). Representative micrographs
and quantification of the data. HL, healthy liver; LM, liver metastasis.
Scale bars, 100 µm.
studies on investigating whether MAMs are required for supporting
the metastatic growth of already disseminated cancer cells. To address
this question, we chemically depletedMAMs in vivo, using clodronate
liposomes36 (CLs). CL treatment was started at day 3 post intrasplenic
injection of KPC cells, a time point in which initial seeding of the
liver by KPC cells has already occurred (Fig. 2e and Supplementary
Fig. 5a,b). As expected, in response to CL treatment, MAM numbers
were significantly reduced (Fig. 2f and Supplementary Fig. 5c).
Interestingly, we could barely detect any αSMA+ myofibroblasts in
metastatic livers of CL-treated mice (Fig. 2f and Supplementary
Fig. 5c). The ablation of MAMs and the prevention of αSMA+
myofibroblast accumulation was not cell line specific because similar
results were observed using Panc02 cells (Supplementary Fig. 5d,e).
Although the metastatic frequency was only modestly affected
by CL treatment in both models, the size of the lesion area
covered by metastatic cells was significantly reduced in response
to macrophage depletion (Fig. 2g,h and Supplementary Fig. 5f,g).
Together, these results suggest that depletion of MAMs prevents the
activation of myofibroblasts and impairs the progression of metastatic
lesions even after initial colonization of the metastatic site by
cancer cells.
Granulin secreted by macrophages triggers myofibroblast
activation
We next sought to understand how MAMs regulate myofibroblast
activation at the metastatic site. In this respect, we found that
macrophage conditioned media (CM) acts as a strong activator
of quiescent primary fibroblasts in culture and enhances their
invasion and proliferation (Supplementary Fig. 6a–c). To identify the
macrophage-derived factors responsible for myofibroblast activation,
we next exposed human THP-1 macrophages to the pancreatic cancer
cell line Panc1 CM in vitro, and performed a secretome analysis.
We identified several extracellular matrix (ECM) proteases associated
with macrophage function37–39 (Supplementary Tables 1 and 2).
Among the most highly secreted proteins we identified granulin
(Grn), a secreted glycoprotein with a relative molecular mass of
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Figure 7 Macrophage-derived granulin induces periostin expression by
hepatic stellate cells in vitro and in vivo. (a) Evaluation of periostin
(Postn) mRNA expression levels in primary hStCs following stimulation with
CM collected from BM WT or Grn−/− macrophages in the presence or
absence of recombinant granulin (rGranulin) (n=3 independent experiments;
mean ± s.e.m.; two-tailed unpaired t-test). (b,c) Evaluation of Postn mRNA
levels by qPCR (b) and periostin protein levels by ELISA (c) in primary
hStCs following stimulation with CM collected from in vivo-derived WT
or Grn−/− MAMs, in the presence or absence of recombinant granulin
(rGranulin) (n= 3 independent experiments; mean ± s.e.m.; two-tailed
unpaired t-test). (d,e) Evaluation of periostin deposition and fibrotic stroma
formation in metastatic livers of control WT mice, WT mice treated with
clodronate liposomes (CL), PI(3)Kγ−/−, Grn−/−, and WT + Grn−/− BM mice
12 days after intrasplenic implantation of KPC cells. (d) Representative
immunofluorescence staining and quantification of periostin deposition.
Nuclei were counterstained with DAPI. (e) Representative Masson’s
trichrome staining (MTS) and quantification of area occupied by fibrotic
stroma (n= 4 mice per condition; four fields assessed per sample; data
combine five independent experiments; mean ± s.e.m.; two-tailed unpaired
t-test). (f) Quantification of Postn mRNA expression levels by qPCR in
intrametastatic myofibroblasts isolated from tumour-bearing livers of WT
and Grn−/− mice, and chimaeric WT + WT BM and WT + Grn−/− BM
mice (data are from six pooled mice per condition; one experiment).
Scale bars, 100 µm.
approximately 70,000 that has previously been shown to mediate
wound healing, by stimulating fibroblast migration40, and to induce
fibrosis in breast cancer41. As the main source of myofibroblasts in
the liver is activated resident hStCs (Supplementary Fig. 3j)16, we
next isolated primary hStCs from mice and stimulated them with
CM generated from primary murine WT BM-derived macrophages
or Grn−/− (granulin deficient) murine BMmacrophages (BMMs).We
found that CM generated from WT, but not from Grn−/−, BMMs
efficiently activated isogenic hStCs and promoted their migration
(Fig. 3a,b). Importantly, addition of recombinant granulin to Grn−/−
BMM CM was sufficient to restore hStC activation and migration
(Fig. 3a,b). Next, we isolated MAMs from tumour-bearing livers
derived from chimaeric WT + WT BM and WT + Grn−/− BM
mice, and prepared MAM CM. We confirmed that only CM from
WT MAMs efficiently induced hStC activation and migration,
whereas CM from Grn−/− MAM was unable to induce activation or
migration of hStCs (Fig. 3c–e). In addition, we found that granulin
expression and secretion is increased in tumour-educated (Fig. 3f,g)
and alternatively (M2-like) activated macrophages (Supplementary
Fig. 6d,e). Together, these data indicate that cancer-cell-derived factors
induce the secretion of granulin in macrophages and that MAMs
activate resident hStCs through granulin.
Granulin is highly expressed in pancreatic cancer metastatic
lesions of mice and humans and MAMs are the main source of
granulin in vivo.
In vivo, we found that within the metastatic tumour micro-
environment, granulin is highly expressed in MAMs, and that
MAMs are the main source of granulin secretion in metastatic
lesions (Fig. 4a,b). When we analysed chimaeric mice harbouring
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Figure 8 Metastatic PDAC patients have increased circulating inflammatory
monocytes that express high levels of granulin. (a) Peripheral mononuclear
cells were isolated from healthy subjects and metastatic PDAC patients.
Representative dot plot of inflammatory monocytes (IMs; CD14hiCD16neg)
and resident monocytes (RMs; CD14dimCD16hi) after gating for the
CD45+CD3negB220negCD19negSytoxneg cell population (data are from 6
different PDAC patients and 6 different healthy subjects). (b) Quantification
of a. Percentage of monocyte populations in healthy subjects and metastatic
PDAC patients (n= 6 different healthy; n= 6 different PDAC samples;
individual data points, horizontal lines represent mean ± s.e.m.; two-
tailed unpaired t-test). NS, not significant. (c) Quantification of Grn mRNA
levels in IMs isolated from metastatic PDAC patients and healthy subjects
(HSs) as described in a,b (n= 3 different healthy, n= 4 different PDAC
samples; mean ± s.e.m.; two-tailed unpaired t-test). (d) Quantification of
Grn mRNA levels in circulating IMs sorted from KPC mice with pathological
confirmed liver metastasis or tumour-free littermates (data are from four
pooled mice per condition; one experiment). (e) Schematic depicting the
role of macrophage-derived granulin in activation of hStCs and in PDAC
liver metastasis. Inflammatory monocytes are recruited to the liver by
metastatic pancreatic tumour cells through a PI(3)Kγ-dependent mechanism.
Once in the metastatic tissue, differentiated macrophages stimulate the
activation and recruitment of resident hStCs through granulin secretion,
resulting in excessive accumulation of myofibroblasts. Granulin-induced
myofibroblasts release high levels of the ECM protein periostin, thereby
enhancing survival and growth of metastatic pancreatic cancer cells in a
hostile environment. Interruption of this sequence, by either preventing
macrophage accumulation or by abolishing granulin expression in recruited
macrophages, limits metastatic growth of pancreatic cancer cells.
tdTomatoRed BM, we found that BM-derivedMAMs, but not resident
KCs, express high levels of granulin (Grn) (Fig. 4c). Surprisingly,
expression levels of Tgfb, a common activator of hStCs42, were low in
MAMs and KCs (Fig. 4c).
Finally, we further confirmed that granulin is highly expressed
in the stroma of spontaneous hepatic metastatic lesions of human
and murine tissues24,43 (Fig. 4d,e and Supplementary Fig. 6f). Taken
together, our findings indicate that granulin is highly expressed by
MAMs and that MAMs are the main source of granulin in PDAC
liver metastasis.
Depletion of granulin prevents liver fibrosis and PDAC
metastatic growth
To investigate whether granulin is required for PDAC metastatic
progression in vivo, we next inoculated Grn−/− and WT mice
with isogenic KPC cells through intrasplenic implantation. We
observed that lack of granulin expression did not alter metastatic
frequency because WT and Grn−/− mice showed similar numbers
of metastatic nodules (Fig. 5a,b). However, the area covered by
metastatic tumour cells in Grn−/− mice was significantly smaller
compared with WT, resulting in an overall significant decrease of
hepatic metastatic tumour burden (Fig. 5a,c). Whereas depletion of
granulin did not reduce the total number ofMAMs (Fig. 5d), nor their
polarization at the metastatic site (Supplementary Fig. 7a), granulin
deficiency abolished the accumulation of activated myofibroblasts
in metastatic liver lesions (Fig. 5d). Quantitative gene expression
analysis of myofibroblast activation markers (Acta2, Fn, Col1a1)16
further confirmed that lack of granulin prevents the activation of
intrametastatic hStCs into myofibroblasts in vivo (Fig. 5e).
Next, we characterized metastatic pancreatic tumour growth in
WT mice transplanted with BM from Grn−/− or WT animals. We
found that depletion of granulin in the haematopoietic compartment
was sufficient to suppress metastatic growth of KPC cells (Fig. 5f,g)
and to prevent myofibroblast activation in vivo (Fig. 5h,i), while
MAM numbers and polarization remained unchanged (Fig. 5j and
Supplementary Fig. 7b). Interestingly, ablation of granulin in the
haematopoietic compartment markedly reduced the number of
proliferating (Ki67+) metastatic pancreatic tumour cells (Fig. 5k),
but apoptotic (cleaved caspase 3+) tumour cell numbers remained
unchanged (Fig. 5l). Taken together, these results suggest that granulin
secretion byMAMs is required for hStCs activation and for metastatic
growth of pancreatic tumours in the liver.
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Granulin induces periostin expression in hStCs thereby allowing
tumour growth
Next, we sought to gain a better understanding of howMAM-induced
myofibroblast activation promotes pancreatic cancer cell growth.
To address this question, we stimulated human fibroblasts with
macrophage CM and performed a mass spectrometry quantitative
analysis of the secretome from fibroblasts exposed to macrophage
CM compared with unexposed fibroblasts.We found thatmacrophage
CM induces fibroblast secretion of proteins associated with ECM
remodelling (Fig. 6a and Supplementary Table 3), and in particular
the secretion of the ECM component periostin (Fig. 6b). Periostin
has been reported to enhance metastatic growth of breast and
colon cancer cells through activation of Wnt and αvβ3–Akt/PKB
signalling pathways, respectively8,44. Thus, we next tested whether
periostin expression by activated myofibroblasts is necessary to
promote pancreatic cancer cell survival and growth. We found
that myofibroblast CM markedly promoted colony formation and
proliferation of PDAC cancer cells, and that addition of a periostin-
neutralizing antibody completely abolished these effects (Fig. 6c
and Supplementary Fig. 7c). We confirmed that periostin acts in a
paracrine myofibroblast–tumour cell loop because we did not detect
any periostin expression in PDAC cells (Supplementary Fig. 7d).
Moreover, we found that periostin was markedly upregulated in
spontaneous hepatic metastatic lesions of human and murine tissues
compared with healthy control livers (Fig. 6d and Supplementary
Fig. 7e). Importantly, the induction of periostin expression in
primary hStCs was strictly dependent on granulin, because CM
generated from Grn−/− BMM (Fig. 7a) and MAMs (Fig. 7b,c) was
unable to induce periostin expression in hStCs. To examine whether
inhibition of myofibroblast activation by MAM-derived granulin
also affects periostin expression and stroma expansion in vivo, we
analysed metastatic liver tissue sections of WT, PI(3)Kγ−/−, Grn−/−,
WT + Grn−/− BM, and WT + CL-treated mice. In all models,
hepatic periostin expression levels and connective tissue deposition
were found to be significantly reduced compared with metastasis-
bearing WT control animals (Fig. 7d,e and Supplementary Fig. 7f,g).
In agreement with these findings, we found that intrametastatic
myofibroblasts isolated from Grn−/− and WT + Grn−/− BM mice
showed an approximately threefold reduction in periostin expression
relative to control myofibroblasts isolated from WT tumour lesions
(Fig. 7f). Taken together, these findings indicate thatMAMs induce the
expression of ECM proteins in myofibroblasts, particularly periostin,
in a granulin-dependent manner which then supports metastatic
pancreatic tumour growth.
Although less frequently, PDAC can also sometimes metastasize
to the lung1. Similar to what we observed in the liver, granulin
was markedly expressed in the stromal compartment of pulmonary
metastatic lesions, especially in areas rich in CD68+ macrophages
(Supplementary Fig. 8a). Depletion of granulin in the haematopoietic
compartment (WT+Grn−/− BM)was sufficient to reduce pulmonary
metastatic growth of PDAC cells, and to prevent myofibroblast
activation, fibrotic stromal expansion, and periostin deposition
in vivo, while MAM numbers remained unchanged (Supplementary
Fig. 8b–e). To further explore whether this mechanism is specific
for the metastatic site, we next analysed primary PDAC tumours for
granulin and periostin expression. Interestingly, we found that at the
primary tumour site granulin is mainly expressed by tumour cells,
and not bymacrophages, while periostin was strongly expressed in the
surrounding stromal compartment (Supplementary Fig. 8f).
Taken together, these data suggest that granulin-expressing
macrophages play a critical role at the metastatic site, but not at the
primary tumour site.
Circulating IMs from metastatic PDAC patients express granulin
As granulin-expressing MAMs originate from the BM, we next
investigated whether circulating IMs express granulin. Therefore, we
collected fresh blood samples from PDAC patients with metastases,
but before therapeutic intervention, and from healthy control
subjects, and purified IMs (CD14hiCD16neg) and resident monocytes
(CD14dimCD16hi) by fluorescence-activating cell sorting45. We found
that the percentage of IMs isolated from metastatic PDAC patients
was significantly higher compared with healthy subjects, while no
differences were observed in the percentage of resident monocytes
(Fig. 8a,b and Supplementary Fig. 8g). Importantly, IMs isolated from
PDAC patients and from metastatic KPC mice exhibited abnormally
elevated granulin expression levels compared with healthy control
subjects (Fig. 8c,d).
DISCUSSION
In this study, we aimed to gain a better understanding of the
role of macrophages in pancreatic cancer metastasis, with the hope
to improve therapies for this devastating disease. In this respect,
we found that MAMs support pancreatic cancer metastasis by
secreting granulin, which consequently promotes the activation of
resident hStCs into αSMA+ myofibroblasts that secrete high levels of
periostin (Fig. 8e). Collectively, our studies provide a comprehensive
functional analysis of stroma–tumour interaction in PDACmetastasis,
and support the rationale for the development of therapeutic
approaches targeting stromal secreted pro-metastatic factors such
as granulin and periostin to disrupt the interrelationship between
MAMs, myofibroblasts and cancer cells. In addition, we observed
an increase of granulin-expressing IMs in blood from metastatic
PDAC patients and metastatic KPC mice compared with healthy
subjects. This observation suggests that granulin could also potentially
be used as a predictive biomarker of PDAC metastasis. However,
to assess the potential use of granulin as a predictive biomarker of
PDAC metastasis, granulin expression levels in IMs derived from
inflammatory, non-cancerous diseases, such as pancreatitis, would be
worth exploring in future analysis.
The fact that MAMs isolated from metastatic lesions secrete high
levels of granulin, but resident macrophages (KCs) do not (Fig. 4c),
indicates that the recruitment of monocyte-derived macrophages is a
critical step during PDAC metastasis. We and others have previously
shown that cancer cells release chemotactic factors, including CCL2,
SDF-1α and mCSF1, to attract pro-tumorigenic monocytes to the
tumour, in a PI(3)Kγ-dependent manner11,35,46–48. Consistent with
this, we found that prevention of macrophage recruitment resulted
in decreased hStCs activation, reduced periostin levels and decreased
metastasis to the liver.
Using an unbiasedmass spectrometry secretome analysis of cancer-
educated macrophages, we identified the glycoprotein granulin.
Granulin has previously been associated with fibroblast activation
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and migration during wound healing40. In addition, in breast
cancer, granulin expression correlates with increased fibrosis and
poor survival5,41. In agreement with a role for granulin in fibrosis,
we found that macrophage-secreted granulin plays a critical role
in PDAC metastasis by activating resident hStCs and stimulating
the secretion of periostin. The precise signalling pathway by
which granulin activates hStCs and primary fibroblasts remains
unknown, as the cognate cell-surface receptor to which granulin
binds is still controversial49–51. Interestingly, depletion of granulin
in the haematopoietic compartment did not change macrophage
recruitment to the liver, macrophage polarization, or CD8 + T cell
infiltration (Fig. 5 and Supplementary Fig. 7).
In agreement with ref. 52, we found that macrophages play a
key role in PDAC metastasis. Whereas ref. 52 describes a role for
resident hepatic macrophages in the establishment of a pre-metastatic
niche that facilitates initial tumour cells seeding, our work focuses
on understanding the subsequent step of metastatic growth. In this
respect, we found that once tumour cells have reached the metastatic
site, their survival and outgrowth capacity critically depends on the
further recruitment of IMs that secrete granulin.
Unfortunately, current imaging approaches are unable to detect
micro-metastases and by the time pancreatic cancer patients are
diagnosed, micro-metastatic spreading has already occurred in most
cases1. Our findings suggest that recruitment of IMs that express
granulin plays a key role in pancreatic cancer metastasis and may
serve both as a prognostic marker, and a potential target for PDAC
liver metastasis. 
METHODS
Methods and any associated references are available in the online
version of the paper.
Note: Supplementary Information is available in the online version of the paper
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METHODS
Cells. Murine pancreatic cancer cells KPC FC1199, referred to as KPC, were
generated in the Tuveson laboratory (Cold Spring Harbor Laboratory, New York,
USA) isolated from PDA tumour tissues obtained from KrasG12D/+; p53R172H/+; Pdx1–
Cre mice of a pure C57BL/6 background as described previously with minor
modifications24. For some experiments, KPCluc/zsGreen cells were generated by using
pHIV Luc–zsGreen (gift from B. Welm, University of Utah, USA, Addgene plasmid
no. 39196) lentiviral particle infection. Infected cells were selected for high zsGreen
expression levels using a flow cytometry cell sorter (ARIA, BD).
Primary murine hepatic stellate cells were isolated from murine livers of 10–12-
week-old female C57BL/6 mice according to previously reported protocols53. The
murine immortalized hepatic stellate cell line from livers of C57BL/6 mice was
provided by T. Sakai’s laboratory, University of Liverpool, UK53. Primary murine
dermal fibroblasts were generated as previously described19. All fibroblasts were used
at an early passage (passage 2–4).
Human primary pancreatic fibroblasts were acquired from Vitro Biopharma,
human peripheral blood monocytic cell line THP-1 and human pancreatic
cancer cell line PANC1 were acquired from ATCC, and murine C57BL/6 Panc02
pancreatic ductal carcinoma cells were obtained from the NCI DCTD Tumor
Repository, NIH.
All cells were cultured inDMEM+ 10% FBS and supplemented with 100 units of
penicillin, 100 µgml−1 streptomycin and 2.5 µgml−1 amphotericin B, except human
primary macrophages and THP-1 cells, which were cultured in RPMI + 10% FBS
and supplemented with penicillin/streptomycin and amphotericin B.
Primary murine macrophages were generated by flushing the bone marrow
from the femur and tibia of C57BL/6 mice followed by incubation for five days
in DMEM containing 10% FBS and 10 ngml−1 murine M-CSF (Peprotech).
For some experiments, differentiated macrophages were polarized into an M1,
M2 or tumour-educated phenotype using INFγ (20 ngml−1, Peprotech) and
LPS (100 ngml−1, Sigma-Aldrich); IL-4 (20 ngml−1, Peprotech); or tumour-
conditioned media, respectively. Primary human macrophages were generated
by purifying CD14+ monocytes from human total blood followed by incubation
for five days in RPMI containing 10% FBS and 50 ngml−1 recombinant human
M-CSF (Peprotech). THP-1 cells were incubated with 50 nM phorbol 12-
myristate 13-acetate for 72 h in RPMI + 10% FBS to generate THP-1-derived
macrophages. For some experiments, differentiated primary macrophages
or THP-1-derived human macrophages were polarized into an M1, M2 or
tumour-educated phenotype using INFγ (50 ngml−1, Peprotech) and LPS
(10 ngml−1, Sigma-Aldrich); IL-4 (40 ngml−1, Peprotech); or tumour-conditioned
media, respectively.
All cells were routinely tested negative for the presence of mycoplasma
contamination. None of the cell lines used in this manuscript is listed in the ICLAC
andNCBIBiosample database ofmisidentified cell lines. Cell lines have been directly
purchased from ATTC and NCI DTCP respectively, as described above.
Mice. We obtained transgenic mice lacking PI(3)-kinase γ expression (p110γ−/−)
on the C57BL/6 background33 from E. Hirsch, Institute of Molecular Biotechnology
Center, University of Torino, Italy. Grn−/− mice (B6(Cg)–Grntm1.1Aidi/J) and
tdTomatoRed mice (B6.129(Cg)–Gt(ROSA)26Sortm4(ACTB–tdTomato,–EGFP)Luo/J) both on
the C57BL/6 genetic background were purchased from The Jackson Laboratory.
C57BL/6 mice were purchased from Charles River. KrasG12D/+; p53R172H/+; Pdx1–Cre
mice24 were purchased from CRUK, Cambridge Research Institute, Cambridge.
All animal experiments were performed in accordance with current UK
legislation under an approved project licence PPL 40/3725 (M. Schmid). Mice
were housed under specific pathogen-free conditions at the Biomedical Science
Unit at the University of Liverpool. In general, for animal studies the group size
was calculated by power analysis using a significance level kept at 5% and the
power at 80% (according to approved corresponding Home Office Project License
Application). For tumour studies, female animals aged 6–8weekswere used.Animals
were randomly assigned to experimental groups. The investigators were not blinded
to allocation during experiments and outcome assessments.
Bone marrow transplantation. Bone marrow transplantation was performed by
reconstituting the bone marrow of lethally irradiated (10Gy) female, 6-week-old
C57BL6 mice by tail vein injection of 5 × 106 total bone marrow cells isolated
from tdTomatoRed mice or Grn−/− mice35. After 4 weeks, successful engraftment
of tdTomatoRed bone marrow was assessed by flow cytometry. WT recipient mice
reconstituted with tdTomatoRed bone marrow showed exclusively tdTomatoRed+
haematopoietic cells, whereas WT recipient mice reconstituted with unlabelled WT
bonemarrow did not show any tdTomatoRed+ signal. After 4 weeks, engraftment of
Grn−/− bone marrow was assessed by genomic DNA PCR according to The Jackson
Laboratory protocol on peripheral blood cells from fully recovered bone-marrow-
transplanted mice. After confirmation of successful bone marrow reconstitution,
mice were enrolled in tumour studies.
Metastasis studies. Experimental liver metastasis was performed by implanting
1 × 106 KPC cells or 1 × 106 Panc02, respectively, unless otherwise stated, in
20 µl PBS into the spleen of immunocompetent isogenic C57BL/6 mice using a
Hamilton 29 G Syringe as previously described32,52. Experimental lung metastasis
was performed by injecting 5 × 105 KPC cells in 200 µl PBS into the tail vein of
immunocompetent isogenic C57BL/6mice using an insulin syringe. At the indicated
time points, mice were euthanized and metastatic tumour burden was assessed
by quantifying the frequency and size of metastatic lesions in haematoxylin and
eosin-stained paraffin-embedded liver or lung sections by microscopy using ZEN
imaging software.
Clodronate liposome treatment. Macrophages were depleted in vivo by
intraperitoneal injections of 200 µl PBS liposomes (Control) or clodronate
liposomes (5mg of clodronate per 1ml) from ClodronateLiposomes.com54.
Flow cytometry. Single-cell suspensions from murine livers were prepared by
mechanical and enzymatic disruption in Hanks balanced salt solution (HBSS) with
1mgml−1 collagenase P (Roche) as previously described55with some modifications.
Briefly, cells in suspension were centrifuged for 5min at 1,200 r.p.m., resuspended in
HBSS and filtered through a 500 µm polypropylene mesh (Spectrum Laboratories).
The cell suspension was resuspended in 1ml 0.05% trypsin and incubated at 37 ◦C
for 5min. Cells were filtered through a 70 µm cell strainer and resuspended in PBS
+ 5% BSA. Cells were blocked for 10min on ice with FC Block (BD Pharmingen,
Clone 2.4G2) and then stained with Sytox viability marker (Life Technologies)
and fluorochrome-conjugated antibodies (Supplementary Table 5). Flow cytometry
was performed on a FACSCanto II (BD Biosciences) and FACS performed on a
FACSAria (BD Biosciences). For FACS experiments, cells were sorted directly into
RLT buffer + β-mercaptoethanol according to the manufacturer’s instructions for
RNA isolation.
Magnetic bead isolation of cells. Samples formagnetic bead isolation were prepared
from livers as described above for preparation of flow cytometry samples. Then
samples were stained and PDGFRα+ or F4/80+ cells were isolated according to the
manufacturer’s instructions (Miltenyi).
Conditioned medium preparation. Conditioned medium from all cells were
generated according to previous reports56. Briefly, the medium was removed from
70% confluent cells and the cells were washed three times with PBS before
addition of serum-free medium. Cells were incubated for 18–24 h in serum-free
medium and then collected and filtered through 0.45 µm filters before use or stored
at−20 ◦C.
Proteomics. To analyse the secretome of cancer-educated macrophages, THP-1-
derived human macrophages were stimulated for 24 h with conditioned medium
from the human pancreatic cancer cell line PANC1. Cells were then washed
three times with PBS and incubated for 24 h in serum-free DMEM. After 24 h of
incubation, over 100ml of cell culture supernatant was collected and filtered through
0.45 µm filters for mass spectrometry. The samples were spiked with 10 µg of human
serum albumin (Sigma-Aldrich) as an internal reference and all proteins in each
sample were concentrated using MWCO 3kDa Amicon Ultra Centrifugal Filtration
Tubes (Millipore) according to themanufacturer’s instructions. The proteinmixtures
were reduced, alkylated, and tryptic-digested as described previously57. Each sample
was individually labelled with a TMT kit (Thermo Scientific), and then aqueous
hydroxylamine solution (5% w/v) was added to quench the reaction. After being
combined, labelled peptide samples were vacuum dried, and then dissolved in
0.1% formic acid for LC–MS/MS analysis. The labelled samples were analysed
using a two-dimensional LC–MS/MS system consisting of a nanoACQUITY
UltraPerformance LC System (Waters) and an LTQOrbitrap Elitemass spectrometer
(Thermo Scientific) equippedwith a nano-electrospray source57. Briefly, 5 µl aliquots
of samples were resolved on a strong cation exchange (5 µm, 3 cm) column,
trapped on a C18 trap column, and then separated on a 200mm microcapillary
C18 column (particle size 3 µm) packed into 100 µm silica tubing. During the
chromatographic separation, the mass spectrometer was operated in a data-
dependent mode at the voltage of 2 kV with acquisition parameters as follows: five
data-dependent CID–HCD dual MS/MS scans per full scan; CID scans acquired
with two-microscan averaging; full scans and HCD scans acquired at resolution
60,000 and 15,000 respectively, with two-microscan averaging; 35% normalized
collision energy (NCE) in CID and 45% NCE in HCD; ±1Da isolation window.
Previously fragmented ions were excluded for 60 s. Each selected parent ion was
first fragmented by CID and then by HCD. MS/MS spectra were analysed against
the Uniprot human database (released 18 March 2013). ProLucid58 was used to
identify the peptides with a precursor mass error of 25 ppm and a fragment ion
mass error of 600 ppm. TMT modification (+229.1629), carbamidomethylation
at cysteine, and oxidation at methionine were considered. For better peptide
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identifications and quantifications, six reporter ions were extracted from the HCD
spectrum within 0.02 mass tolerance using home-made software and inserted
into the corresponding CID spectrum with the same precursor ions59. The output
data files were filtered and sorted to compose the protein list using DTASelect60
with ≥2 peptides assignments for a protein identification and a false positive
rate ≤0.01.
For quantitative analysis, Census in IP2 pipeline (Integrated Proteomics) was
used. Protein abundance was calculated from the average of a reporter ion’s
intensities from all constituent peptides from a protein61. Two different TMT
reagents were used to control the quality in quantification, and data with ≥30%
variation were excluded. Relative protein abundance was calculated from the ratios
of reporter ion intensities.
To identify secreted proteins in the THP-1macrophages, the full list of identified
proteins was analysed using the gene ontology consortium web page for the GO
term ‘Extracellular Vesicular Exosome’ (Gene ontology: tool for the unification
of biology62) and then referenced to the Uniprot database (www.uniprot.org)
for confirmation.
Dermal fibroblast/hepatic stellate cell activation. Primary PDGFRα+ murine
dermal fibroblasts or hepatic stellate cells were isolated as previously described19,53.
On the day before stimulation, dermal fibroblasts were washed three times
with PBS and then incubated overnight in DMEM + 1%FBS. The next
morning, dermal fibroblastswere stimulatedwithmacrophage-conditionedmedium
(supplemented with 1% FBS) or DMEM + 1%FBS as a control and incubated
for 24 h.
Murine hepatic stellate cells were washed three times with PBS and then
incubated overnight in DMEM + 2%FBS. The next morning, hepatic stellate cells
were stimulated with macrophage-conditioned medium (supplemented with 2%
FBS) from WT or Grn−/− macrophages or DMEM + 2%FBS as a control and
incubated for 24 h. To rescue the phenotype from Grn−/− macrophage-conditioned
medium, Grn−/− MCM were supplemented with recombinant murine progranulin
(R&D Systems, 2557-PG-050) at 1 µgml−1 for activation experiments.
ELISA.Hepatic stellate cells were stimulatedwithmacrophage-conditionedmedium
(supplemented with 2% FBS) fromWTorGrn−/−macrophages or DMEM+ 2%FBS
as a control and incubated for 24 h. After 24 h, the hepatic stellate cells were washed
three times with pre-warmed PBS and then incubated for 48 h in serum- and
phenol red-free DMEM. After 48 h, the medium was collected and used for ELISA
to measure periostin according to the manufacturer’s instructions (R&D Systems,
MOSF20). For murine macrophages, cells were stimulated with KPC- or Panc02-
conditioned medium for 24 h, then washed three times with PBS and incubated
in serum- and phenol red-free DMEM. The conditioned medium was collected
after 48 h and used for ELISA to measure granulin according to the manufacturer’s
instructions (LS Bio, LS-F284)
Transwell migration assay. Transwell inserts with 8 µm pore size (Corning) were
coated with 50 µl growth factor-reduced Matrigel (BD Biosciences) and allowed to
solidify. Macrophages were seeded in DMEM+ 10%FBS in a 24-well plate. Growth
medium was removed, cells were washed three times with PBS, and DMEM + 1%
FBS was added. Next, fibroblasts were added in DMEM + 1% FBS into the inserts
and allowed to migrate through the insert membrane for 48 h. The inserts were
removed, and the inside was swabbed thoroughly with cotton swabs and then fixed
inmethanol containing 0.05% crystal violet. The number ofmigrated fibroblasts was
counted by bright field microscopy. For Transwell migration of hepatic stellate cells,
the hepatic stellate cells were labelled with Vybrant Dil (Life Technology, emission
565) according to themanufacturer’s protocol before addition to the inserts. Relative
migration was evaluated by the amount of pixels from each condition relative to the
pixels from the control using Zen Software.
Proliferation assay. Human primary pancreatic fibroblasts were seeded at a
concentration of 2,000 cells per well in 96-well plates in DMEM + 10% FBS.
Cells were washed three times with PBS and then stimulated with conditioned
medium (supplemented with +1% FBS) prepared from primary human or THP-1
macrophages or DMEM+ 1% FBS as a control.
Cell viability was determined by measuring the conversion of water-soluble 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to an insoluble
formazan. The concentration of formazan was determined by optical density
at 595 nm.
KPC cells were seeded at a concentration of 2,000 cells per well in 96-well
plates in DMEM + 10% FBS. Cells were washed three times with PBS and
then stimulated with serum-free DMEM as a control or hepatic stellate cell-
conditionedmediumwith orwithout a neutralizing antibody against periostin (R&D
Systems, AF2955). Cell viability was determined as described by measuring after 48
and 72 h.
Multicellular colony formation assay. Tumour cells were strained through a 70 µm
cell filter to ensure a single-cell suspension. The cells were then embedded at a
concentration of 2,000 cells per well in a 0.3% agar mix consisting of either DMEM
+ 5%FBS (control) or myofibroblast-conditionedmedium+ 5%FBS. A neutralizing
anti-periostin antibody (murine: R&D Systems, AF2955; human: Abcam14041)
was incubated for 10min with the myofibroblast-conditioned medium before
embedding into the agar matrix. A layer of control medium or myofibroblast-
conditioned medium was added on top of the agar matrix with or without the anti-
periostin antibody. The colonies were fixed and stained with 0.05% crystal violet in
methanol/PBS and the number of colonies per well was counted at day 14 after cell
seeding by bright-field microscopy.
RT–qPCR. Cells were lysed in RLT buffer +β-mercaptoethanol according to
the manufacturer’s instructions for RNA isolation. Total RNA purification was
performed with the RNeasy kit and cDNA was generated using QuantiTect Reverse
Transcription Kit (Qiagen) according to the manufacturer’s instructions. Total
RNA (500 ng) was used to generate cDNA. RT–qPCR assays were performed with
LightCycler 480 SYBR Green I Master Mix (Roche) on a LightCycler 480 (Roche).
Relative expression levels were normalized to Gapdh expression according to the
formula 2−(CT for gene of interest−CT Gapdh). Fold increase in expression levels was calculated
by the comparative CT method 2−11CT (ref. 63).
Primers are listed in Supplementary Table 4.
Immunofluorescence. For human tissue sections, antigen retrieval was carried
out in high-pH buffer using the Dako PT-Link System. Tissue sections were
blocked in PBS + 0.1% bovine serum albumin and 8% normal goat serum
prior incubation with primary antibodies. Tissue sections were stained with
secondary antibodies including DAPI (Life Technologies) and mounted using Dako
Fluorescent Mounting Medium.
Murine liver tissues were embedded in Optimal Cutting Temperature (OCT)
medium and stored at −80 ◦C. Tissue sections were fixed in ice-cold acetone,
permeabilized with PBS+ 0.1% Triton X-100, blocked with PBS+ 8% normal goat
serum, and incubated with primary antibodies. Next, tissue sections were washed in
PBS, stained with secondary antibodies including DAPI (Life Technologies, 1:100)
andmounted usingDako FluorescentMountingMedium. Goat anti-rat or goat anti-
rabbit secondary antibodies conjugated to AlexaFluor488 and AlexaFluor594 were
used (Abcam, 1:500).
Livers from experiments involving ZsGreen/Luciferase-transfected cells were
fixed using a sucrose gradient method to preserve the zsGreen fluorescence64. All
tissue sections were imaged using an Axio Observer Light Microscope with the
Apotome.2 (Zeiss) and quantified using the Zen Software (Zeiss). Antibodies are
listed in Supplementary Table 5.
Immunohistochemical analysis. Deparaffinization and antigen retrieval was
performed using an automated DAKO PT-link. Paraffin-embedded human and
mouse PDA tumours were immunostained using the DAKO envision+ system-
HRP. Tissue sections were incubated with primary antibodies followed by HRP-
conjugated secondary antibody (from DAKO envision kit). Staining was developed
using diamino-benzidine and counterstained with haematoxylin. Antibodies are
listed in Supplementary Table 5.
Connective tissue staining (Masson’s trichrome staining). Masson’s trichrome
staining was performed according to the manufacturer’s instructions (Abcam
ab150686).
Human studies.Human studies using blood samples were approved by the National
Research Ethnics (NRES) Service Committee North West—Greater Manchester
North 08/H1011/36 and NRES Committee NorthWest—Cheshire 11/NW0083 and
REC15/NW/0477. Human blood samples were obtained from advanced PDAC
patients with liver metastasis (all pathologically confirmed) or from control healthy
subjects. All individuals provided informed consent for blood donation on approved
institutional protocols. Blood was collected in sodium heparin (NaH) tubes and
immediately processed for mononuclear cell isolation using gradient centrifugation
(Histopaque 1077, Sigma-Aldrich) according to the manufacturer’s protocol.
Mononuclear cells were resuspended in PBS + 2% BSA and blocked using
human TrueStain FcX (Biolegend) following by staining with antibodies and
the viability marker SYTOX Green (Life Technologies). Flow cytometry analysis
was performed on a FACSCanto II (BD Biosciences) and flow-cytometry-
based cell sorting was performed on a FACSAria (BD Biosciences). For cell
sorting, cells were sorted directly into RLT buffer +β-mercaptoethanol according
to the manufacturer’s instructions for RNA isolation (see qPCR section for
further details).
Paraffin-embedded human tissue sections from control healthy subjects and
advanced PDAC patients with liver metastasis were obtained from the Liverpool
© 2016 Macmillan Publishers Limited. All rights reserved
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Tissue Bank, University of Liverpool, UK or approved by NRES Committee North
West –Cheshire REC15/NW/0477. All samples were pathologically confirmed.
Statistics and reproducibility. The level of significance was determined by a two-
tailed unpaired Student’s t-test and analysed with GraphPad Prism5 software.
P<0.05 was considered significant.
Immunohistochemical and immunofluorescence analyses of human healthy and
metastatic liver biopsies (Figs 1a, 4e, 6d and Supplementary Fig. 1a–c) are shown
from n= 5 healthy subjects and n= 5 metastatic patients, and human primary
PDAC tumour (Supplementary Fig. 8f) n= 4. Images were acquired and analysed
using five different visual fields from each tissue section. For immunohistochemical
and immunofluorescence analysis of murine tissue sections, the following numbers
of different visual fields from each tissue section were analysed: Supplementary
Fig. 4e (2 fields); Supplementary Fig. 3d (3 fields); Figs 1c,d,f, 2d, 5d,h and 7d,e
(4 fields); Figs 2f, 4d, 5j,k and 6d, and Supplementary Figs 5e and 8a,c–e (5
fields), Supplementary Figs 6f and 7e (8 fields). For Figs 2b,c,g,h and 5b,c,f,g,
and Supplementary Figs 4c,d, 5f,g and 8b all metastatic nodules were counted
and measured (size) within one liver section. Numbers of different samples used
to acquire images are reported in the corresponding figure legends. Transwell
migration assays (Fig. 3b,d) are shown as the mean from n = 3 independent
experiments. For each experiment, 10 different visual fields per condition were
counted. Colony formation assays (Fig. 6c) are shown as the mean from n= 3
independent experiments; total number of colonies per cell type per experiment was
counted. qPCR analysis (Fig. 3a,c,f and Supplementary Figs 6d,e and 7d) are shown
as the mean from n=3 independent experiments. qPCR analyses of in vivo-derived
murine cells are shown as the mean from three technical replicates whereby samples
were pooled from several animals fromeach condition: Figs 4a,c and 5e (three pooled
mice); Fig. 8d (four pooledmice), Fig. 5i (five pooledmice), Figs 5l and 7f (six pooled
mice); qPCR analyses of in vivo-derived human cells are shown as mean from n=3
healthy and n=4 PDAC patients (Fig. 8c). ELISA analyses (Figs 3g, 4b and 7c) are
shown as the mean from n=3 independent experiments, whereby two (Figs 4b and
7c) and three (Fig. 3g) technical replicates per condition per experiment were used.
Access to public repository for mass spectrometry data.Mass Spec data have been
placed in the public repository MassIV database, accession IDMSV000079491 with
the title ‘THP_1 and human fibroblast secretomes’.
Direct link: ftp://massive.ucsd.edu/MSV000079491.
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Supplementary Figure 1 Morphological characterisation of metastatic PDAC 
lesions in human and mouse. (a) Lower magnification of representative 
micrographs shown in Fig. 1a. Identification of pan-cytokeratin (CK)+ 
metastatic pancreatic cancer cells, hematopoietic cells (CD45+), 
macrophages (CD68+) and myofibroblasts (αSMA+) as predominant 
cell types at the hepatic metastatic microenvironment of pancreatic 
cancer by immunohistochemical analysis of human biopsies (data are 
from 5 PDAC patients and 5 healthy subjects; five fields assessed per 
sample). HL= healthy liver, LM = liver metastasis.  (b) Identification of 
cytokeratin (CK) 19+ metastatic pancreatic cancer cells, tumour associated 
macrophages (CD68+) and myofibroblasts (PDGFRα+) as predominant cell 
types at the hepatic metastatic microenvironment of pancreatic cancer 
by immunofluorescence analysis of human biopsies. Representative 
micrographs are shown and quantification of data (n= 5 PDAC, n = 5 
healthy subjects; five fields assessed per sample; mean ± s.e.m; two-tailed 
unpaired t-test). HL= healthy liver, LM=liver metastasis.  (c) Representative 
Masson’s trichrome staining and quantification of area occupied by fibrotic 
stroma in human biopsies (n= 5 PDAC patients, n = 5 healthy subjects; 
five fields assessed per sample; mean ± s.e.m; two-tailed unpaired t-test). 
HL= healthy liver, LM=liver metastasis.  (d)  Experimental metastasis model 
by intrasplenic implantation of 1x106 KrasG12D;Trp53R172H;Pdx1-Cre 
(KPC) mice derived pancreatic cancer cells expressing a luciferase/zsGreen 
lentiviral reporter plasmid (KPCluc/zsGreen). Liver tissues were isolated at 
day 5 and day 12 post implantation. (Upper panel) Liver tissue sectioned 
stained by Hematoxylin and Eosin (HE) showing initial micrometastatic 
lesions of disseminated cancer cells at day 5 post implantation followed 
by the generation of an excessive stromal microenvironment surrounding 
disseminated cancer cells at day 12 post implantation. (Lower panel) 
Representative immunofluorescence staining of disseminated KPCluc/zsGreen 
(zsGreen) cells. Data are from 6 mice per time point; four fields assessed 
per sample; data combine two independent experiments. Scale bars = a, 
200 µm; b, c, d, 100µm.
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Supplementary Figure 2 FACS-based quantification of immune cell 
infiltrating the metastatic site in PDAC. Experimental metastasis 
model by intrasplenic implantation of 1x106 KPC-derived pancreatic 
cancer cells. After 12 days, liver tissues were isolated, enzymatically 
digested and resulting single cell suspensions were stained for flow 
cytometry analysis. Naïve livers were used as controls (healthy). 
(a) Representative flow cytometry dot plots showing gating 
strategy used to quantify intrametastatic B cells (CD45+B220+), 
T cell (CD45+CD3+), NK cells (CD45+NK1.1+CD3negB220neg), 
Neutrophils (CD45+CD11b+F4/80negLy6G+Ly6C+, inflammatory 
monocytes (CD45+CD11b+F4/80negLy6GnegLy6C+) and macrophages 
(CD45+CD11b+F4/80+). Only viable cells (SYTOXneg) were used (data are 
from 5 healthy livers or 8 liver metastasis; repeated two times with similar 
results). (b) Quantification of CD45+ hematopoietic cells detected in 
healthy control livers (Ctrl) and metastatic tumour bearing livers (LM) (n = 
5 Ctrl mice; n = 8 LM mice; data combine two independent experiments; 
individual data points, horizontal lines represent mean ±  s.e.m; two-tailed 
unpaired t-test).  (c) Percentage of intrametastatic immune cells among 
total viable cells gated according to (a) in healthy control livers (Ctrl) and 
metastatic tumour bearing livers (LM) (individual data points, horizontal 
lines represent mean ±  s.e.m; two-tailed unpaired t-test). Data shown 
combine two independent experiments; total mice: n = 5 Ctrl mice, n = 6 
LM mice (B220, NK1.1, CD3); n = 5 Ctrl mice; n = 9 LM mice (Ly6G, Ly6C, 
F4/80).  (d) Representative flow cytometry dot plots showing gating strategy 
to analyse CCR2 (CD192) expression levels. Intrametastatic inflammatory 
monocytes (CD45+CD11b+F4/80negLy6GnegLy6C+) and macrophages 
(CD45+CD11b+F4/80+) express CCR2 (data are from 5 Ctrl mice or 8 LM 
mice; repeated two times with similar results). ns, not significant.
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Supplementary Figure 3 Liver PDAC metastasis induces the recruitment of 
monocyte-derived macrophages, followed by the activation of resident hStCs. 
(a, b) Experimental metastasis model by intrasplenic implantation of 1x106 
KPC cells. (a) Intrametastatic CD11b+ cells showing a marked expansion of 
the macrophage population (F4/80+, blue) in established macro-metastatic 
lesions (day 12, D12), while inflammatory monocytes (Ly6C+Ly6Gneg, red) 
predominantly increased during early micro-metastatic spreading (day 5, 
D5).  Ctrl= 5 mice; Day 5 = 2 mice, Day 12 = 5 mice; data combine two 
independent experiments. (b) Representative immunofluorescence staining 
showing increased CD11b+ cells (upper) in micro-metastatic livers, followed 
by excessive accumulation of aSMA+ myofibroblasts in livers with macro-
metastatic lesions. Macrophages (lower) are equally distributed in healthy livers 
(Kupffer cells) and show increase clustering in tumour bearing livers. Data are 
from 6 mice per time point; two independent experiments. (c) Representative 
Masson’s trichrome staining (MTS) of healthy control liver indicating absence 
of fibrotic stroma (lack of blue colour). Data are from 6 mice; two independent 
experiments. (d) Statistical comparison showing a positive correlation (Pearson) 
between increased numbers of aSMA+ myofibroblasts and area occupied by 
metastatic cancer cells in tumour bearing murine livers. solid line = best fit, 
dashed lines, 95% confidence intervals. Total n = 20 mice; four independent 
experiments. (e - g) Primary tumours and spontaneous metastatic hepatic 
tumours derived KPC mice. (e) Representative HE images showing the 
presence of an excessive stromal compartment at both sites (data are from 5 
mice per condition, four fields assessed per sample). (f) Representative images 
of liver tumour sections stained for MAMs (F4/80+), pancreatic cancer cells 
(CK19+), or myofibroblasts (aSMA+) showing the presence of an excessive 
metastatic microenvironment mainly consisting of MAMs and myofibroblasts 
surrounding the tumour cells (data are from 5 mice per condition, four fields 
assessed per sample). (g) Flow cytometry analysis showing a marked expansion 
of the macrophage population (F4/80+) in metastatic livers (ML) compared to 
healthy livers (HL) (n = 5 mice per condition, data combine five independent 
experiments; mean ± s.e.m.; two-tailed unpaired t-test).  (h - j) Chimeric WT + 
tdTomatoRed BM (WT+tdTR BM) mice. (h) Successful BM reconstitution was 
confirmed by flow cytometry analysing total circulating CD11b+Gr1+ cells. (i, 
j) Representative images showing co-localization of tdTomatoRed signal with 
F4/80+ MAMs (i), but not with aSMA+ myofibroblasts in the metastatic lesion 
(below white line). Data are from 6 mice per condition; one experiment. Scale 
bars, b, c, f, 100µm; e, 50µm; i, j, 25µm.
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Supplementary Figure 4 The recruitment of monocyte derived 
macrophages is necessary for efficient pancreatic cancer metastasis. 
1x106 KPC-derived cells (a) or 1x106 Panc02 cells (b - e) were 
intrasplenically injected into age and sex matched WT and PI3Kg-/- (-/-) 
mice. After 12 days, total livers were harvested and analysed by flow 
cytometry, immunohistochemistry, and immune fluorescence based 
methods. (a) Representative HE staining of liver tissue sections showing a 
marked decreased size of metastatic tumours in livers of PI3Kg deficient 
(-/-) mice (data are from 7 WT and 9 PI3Kg-/- mice; data combine two 
independent experiments). (b) Percentage of intrametastatic macrophages 
among CD45+ cells quantified by flow cytometry. PI3Kg deficiency (-/-) 
results in a marked reduction of MAMs compared to WT (n = 6 mice 
per condition; one experiment; individual data points, horizontal lines 
represent mean ±  s.e.m; two-tailed unpaired t-test). (c, d) Quantification 
of metastatic frequency (c) and average metastatic lesion size (d) in WT 
and PI3Kg knockout mice (-/-) by hematoxylin and eosin (HE) stained 
liver sections (n = 6 mice per condition; all metastatic nodules assessed 
from one section per sample; one experiment; c, individual data points, 
horizontal lines represent mean ±  s.e.m; d, mean ±  s.e.m; two-tailed 
unpaired t-test). (e) Representative immunofluorescence staining and 
quantification of myofibroblasts (aSMA+) cell frequency in livers in WT 
and PI3Kg knockout mice (-/-). Nuclei were counterstained with DAPI (n 
= 6 mice per condition; two fields assessed per sample; one experiment; 
mean ±  s.e.m; two-tailed unpaired t-test).
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Supplementary Figure 5 Disseminated PDAC cells depend on MAMs to sustain 
growth after colonization of the metastatic site. (a, b) In vivo bioluminescence 
imaging to monitor metastatic colonization of the liver (a) Representative 
image showing radiance of a mouse two days post intrasplenically implantation 
of 1x 106 PDAC cancer cells (KPCluc/zsGreen) and tumour free control mouse. 
Main signal detected originates from the liver area, while some residual signal 
is measured from the injection site, the spleen. (b) Quantification of radiance 
(total flux) measure two days post implantation confirming colonization of 
the liver by implanted cancer cells has occurred (data are from 2 control or 
10 KPCluc/zsGreen mice; one experiment, individual data points, horizontal 
lines represent mean).  (c) Representative flow cytometry dot plots and 
quantification showing a marked reduction of macrophages (F4/80+) and 
myofibroblasts (PDGFRα+) in KPC cell induced tumour bearing livers of mice 
treated with Clodronate Liposomes (CL) compared to control mice treated with 
PBS Liposomes (PL) (n = 3 mice per condition; one experiment; individual 
data points, horizontal lines represent mean ±  s.e.m; two-tailed unpaired 
t-test). (d) Percentage of macrophages (F4/80+) among viable cells in Panc02 
cell induced tumour bearing livers of mice treated with Clodronate Liposomes 
(CL, data from 2 mice) compared to control mice treated with PBS Liposomes 
(PL, data from 2 mice) (one experiment; individual data points, horizontal 
lines represent mean). (e) Representative immunofluorescence staining and 
quantification of MAMs (F4/80+) and myofibroblasts (aSMA+) cell frequency in 
Panc02  cell induced liver tumours of mice treated with liposomes containing 
control PBS (PL) or clodronate (CL). Nuclei were counterstained with DAPI (n 
= 4 mice per condition; five fields assessed per sample; one experiment; mean 
±  s.e.m; two-tailed unpaired t-test). (f, g) Evaluation of metastatic frequency 
(f) and lesion area covered by metastatic cells (g) in Panc02 tumour bearding 
livers of mice treated with liposomes containing control PBS (PL) or clodronate 
(CL). Nuclei were counterstained with DAPI (n = 5 mice per condition; all 
metastatic nodules assessed from one section per sample; one experiment; 
individual data points, horizontal lines represent mean ±  s.e.m; two-tailed 
unpaired t-test). Scale bars, 100µm. 
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Supplementary Figure 6 High levels of granulin are specifically expressed 
by tumour educated macrophages in vitro and in vivo. (a) Quantification 
of aSMA (Acta2) and collagen 1a (Col1a) mRNA levels in primary murine 
dermal fibroblasts stimulated with isogenic macrophage conditioned 
media (CM) as determined by qPCR. Bar graph show fold up regulation 
compared to unstimulated and are displayed as mean (data are from a 
single experiment, repeated four times with similar results; Supplementary 
Table 6). (b) Quantification of human (green) and mouse (red) myofibroblast 
that migrated towards human and mouse macrophages, respectively, in a 
matrigel-coated transwell assay (n = 4 independent experiments; mean ± 
s.e.m.; two-tailed unpaired t-test)  (c) Quantification of human myofibroblast 
proliferation in the presence of control media, THP-1 derived macrophage 
CM, or primary macrophage CM (n = 4 independent experiments; mean ± 
s.e.m.; two-tailed unpaired t-test).   (d) Quantification of granulin mRNA 
expression levels by qPCR in human primary unstimulated macrophages 
(M0) or primary macrophages stimulated with either interleukin (IL) -4 
(M2-like phenotype), interferon (IFN) g / LPS (M1-like phenotype) or 
educated with tumour conditioned media generated from human Panc1 
cells (n = 3 independent experiments mean ± s.e.m.; two-tailed unpaired 
t-test).  (e) Quantification of granulin mRNA expression levels by qPCR 
in murine primary macrophages stimulated with either interleukin (IL) 
-4 (M2-like phenotype), interferon (IFN) g / LPS (M1-like phenotype) or 
educated with tumour conditioned media generated from murine KPC 
and Panc02 PDAC cancer cells (n = 3 independent experiments; mean 
± s.e.m; two-tailed unpaired t-test).   (f) Metastatic hepatic tumours 
derived from the spontaneous mouse pancreatic cancer model Pdx1Cre-
ERT;KrasG12D;Trp53R172H; (PdxCre-ERT KP mice) were isolated and 
morphometrically analysed. Representative images of immunohistochemistry 
staining for MAMs (CD68+) and granulin expression on serial tissue sections 
from metastatic lesions and healthy liver and quantification of the data (n 
= 1 mouse per condition; eight fields assessed per sample; bars represent 
means). ns, not significant.
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Supplementary Figure 7 Depletion of granulin does not affect the 
recruitment of macrophage to the metastatic site, their activation, or 
intrametastatic effector T cell numbers, but markedly reduces stromal 
expansion. 5x105 KPC-derived cells were intrasplenically injected into WT 
and Grn-/- mice (a), and chimeric WT+ WT BM and WT + Grn-/- BM mice (b). 
After 12 days, total livers were harvested and analysed my flow cytometry. 
(a) Quantification of intrametastatic total MAMs (F4/80+), CD206+ MAMs, 
and CD8+ effector T cells by flow cytometry isolated from WT and Grn-
/- mice (n = 6 mice per condition; one experiment; individual data points, 
horizontal lines represent mean ±  s.e.m; two-tailed unpaired t-test). (b) 
Quantification of intrametastatic total MAMs (F4/80+), CD206+ MAMs, 
and CD8+ effector T cells by flow cytometry isolated from WT + WT BM 
and WT + Grn-/- BM mice mice (n = 6 mice per condition; one experiment; 
individual data points, horizontal lines represent mean ±  s.e.m; two-tailed 
unpaired t-test). (c) Quantification of murine KPC cancer cell proliferation 
in the presence or absence of Mf CM and periostin neutralising antibody 
(anti-Periostin) (n = 4 independent experiments; mean +/- SEM; two-
tailed unpaired t-test). (d) Quantification of periostin expression by qPCR 
in primary activated murine myofibroblasts and KPC cells. Periostin 
expression was undetectable in KPC cells while myofibroblasts expressed 
high levels of periostin (n = 3 independent experiments; mean ± s.e.m).  
(e) Immunohistochemical analysis of periostin in healthy liver (HL) and 
spontaneous metastatic livers (ML) collected from Pdx1-CreERT KP mice, 
respectively. Representative micrographs and quantification of the data 
are shown (n = 1 mouse per condition; eight fields assessed per sample; 
bars represent means). (f, g) Representative images of the evaluation of 
periostin deposition and fibrotic stroma formation (MTS) in metastatic livers 
of control WT, WT mice treated with clodronate liposomes, PI3Kg-/-, Grn-/-, 
and WT + Grn-/- BM mice 12 days after intra-splenic implantation of KPC 
cells (data are from 4 mice per condition, four fields assessed per sample; 
data combine five independent experiments). Scale bars = 100mm. NS, not 
significant.
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Supplementary Figure 8 Depletion of granulin in the hematopoietic 
compartment reduces pulmonary metastasis and myofibroblast activation 
in the lung. (a - e) 5x105 KPC-derived cells were intravenously injected into 
age and sex matched chimeric WT + WT BM and WT + Grn-/- BM  mice. 
After 12 days, total lungs were harvested and analysed. (a) Representative 
images of immunohistochemistry staining for MAMs (CD68+) and granulin 
expression on serial tissue sections from lung metastatic lesions and 
quantification of the data (data are from 5 WT + WT BM mice or 4 WT 
+ Grn-/- BM mice; four fields assessed per sample; one experiment). (b) 
Representative images and quantification of WT BM and Grn-/- BM derived 
lung tissue stained with HE showing a marked reduction of area covered 
by metastatic cancer cells in Grn-/- BM mice compared to WT BM mice 
(mean ± s.e.m.; two-tailed unpaired t-test), while frequency of metastatic 
lesions (metastatic foci) remained unchanged (n = 5 WT + WT BM mice, 
n = 4 WT + Grn-/- BM mice; all metastatic nodules assessed from one 
section per sample; one experiment; individual data points, horizontal line 
represents mean ± s.e.m.; two-tailed unpaired t-test). (c) Representative 
immunofluorescence staining and quantification of MAMs (F4/80+) and 
myofibroblasts (aSMA+) cell frequency in tumour bearing lungs of WT + 
WT BM and WT + Grn-/- BM mice. Nuclei were counterstained with DAPI 
(n = 5 WT + WT BM mice, n = 4 WT + Grn-/- BM mice; five fields assessed 
per sample; one experiment; mean ± s.e.m.; two-tailed unpaired t-test). 
(d) Representative immunofluorescence staining and quantification of 
periostin expression in tumour bearing lungs of WT + WT BM and WT + 
Grn-/- BM mice. Nuclei were counterstained with DAPI (n = 5 WT + WT 
BM mice, n = 4 WT + Grn-/- BM mice; five fields assessed per sample; one 
experiment; mean ± s.e.m.; two-tailed unpaired t-test). (e) Representative 
Masson’s trichrome staining and quantification of area occupied by fibrotic 
stroma in tumour bearing lungs of WT + WT BM and WT + Grn-/- BM mice 
(n = 5 WT + WT BM mice, n = 4 WT + Grn-/- BM mice; five fields assessed 
per sample; one experiment; mean ± s.e.m.; two-tailed unpaired t-test). 
(f) Immunohistochemical analysis of periostin and granulin expression in 
human primary PDAC tumours. Representative micrographs are shown (data 
are from 4 different patients per condition). (g) IM from blood samples from 
healthy subjects and metastatic PDAC patients expressed high levels of the 
chemokine receptor CCR2 (CD192). Representative histogram shown from 
6 different samples per condition. Scale bars a, b, c, e, f, 100 µm; d, e,  
200 µm; inset, 20 µm.
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Supplementary Tables
Supplementary Table 1: Identified proteins in tumour educated macrophage secretome. 
Top 20 identified proteins secreted by tumour educated macrophages are listed according to their abundance.
Supplementary Table 2. Secretome macrophages. 
Complete list of secreted proteins associated with GO term “Extracellular Vesicular Exosome” identified by mass spectrometry in human macrophages 
educated with Panc1 conditioned media.
Supplementary Table 3. Secretome myofibroblasts. 
Complete list of secreted proteins associated with GO term “Extracellular Matrix Organistion” identified by mass spectrometry as differentially expressed in 
human fibroblasts educated with primary macrophage conditioned media compared to unstimulated fibroblasts. 
Supplementary Table 4: Primers. 
List of primers used for qPCR analysis in this study.
Supplementary Table 5: Antibodies.
 List of antibodies used in this study.
Supplementary Table 6: Statistics source data.
Activation assays primary dermal fibroblasts.
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